Terasaki Institute for Biomedical Innovation Encourages People to Become Living Kidney Donors With PSA Airing on CBS

March 8, 2021

(Los Angeles) — Terasaki Institute for Biomedical Innovation has joined the OneLegacy Foundation and other like-minded organizations from around the country to help create an important public service announcement and website encouraging people to consider being a living kidney donor. The #BeLikeGina campaign launches this week in conjunction with National Kidney Month and is connected to CBS’s highly-acclaimed BPositive program.

Microneedle Patches For Microdosing Psychedelic Pharmaceuticals

February 22, 2021

(LOS ANGELES) – Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive results when testing them for medical use. Research has shown that drugs such as MDMA (a type of methamphetamine), LSD and psilocybin (“magic mushrooms”) can be of benefit in treating severe pain, anxiety, depression and certain mental illnesses. Successful outcomes have been achieved when using psychedelics for treating conditions such as post-traumatic stress disorder and addictions to alcohol and smoking, for example. In many cases, these treatments have benefited individuals who had unsuccessfully tried to treat their conditions by other methods.

Breast Cancer-on-a-Chip For Testing Immunotherapy Drugs

February 1, 2021

(LOS ANGELES) – There are many mechanisms by which the body responds to foreign invaders.  One of these involves the T-cells of the immune system, which have a number of different proteins on their surface called “checkpoint proteins.”  These checkpoint proteins bind to proteins on the surface of other cells and can result in either stimulation or suppression of T-cell activity.  Normally, surface proteins on foreign or invading cells will produce a stimulation of T-cell activity against these cells, while T-cell suppression is a built-in mechanism to prevent the immune system from attacking the body’s own normal cells.  

2020 Year in Review: Championing Patient-Centered Work

January 19, 2021

With 2020 winding down, let’s take a moment to reflect on all that we have accomplished this year for the transplant and living donation community. Together with our partners, we launched the COVID-19 Kidney / Transplant Listening and Resource Center, designed new education for living donors and transplant recipients in partnership with the community, presented our work on digital storytelling and innovative education tools at talks and conferences hosted by the American Transplant Congress, Astellas Pharma Inc., One Lambda Inc., the 2020 Canadian Society of Transplantation Virtual Forum, and continued training new researchers and scientists in the field. We also published more than 20 new papers, book chapters, abstracts, and commentaries. This year we faced unprecedented challenges due to the COVID-19 pandemic, but we were able to pull together to meet those challenges in new and innovative ways to support highly at-risk patients. The transition to the remote environment has led us to some of our best projects yet!

COVID-19 Vaccine Recent Developments and Recommendations for Transplant Patients

January 15, 2021

At TIBI and at Transplant Research and Education Center (TREC), we believe that rapid communication of information about COVID-19 vaccination to transplant patients and ongoing monitoring of patient outcomes are two important ways to keep patients safe as we move forward into 2021. 

Visible Hydrogels For Rapid Hemorrhage Control and Monitoring

December 21, 2020
(LOS ANGELES) – There are many different events which may lead to excessive and uncontrolled bleeding within the body. This can occur as a result of inflammation and ulcerations, abnormalities in the blood vessels or trauma-related injuries. Individuals with predisposing conditions, such as cardiac patients, are at particular risk of internal bleeding due to the anticoagulants they are often prescribed as a preventive measure. They are also prone to gastrointestinal bleeds, affecting 40% of patients who are on cardiac assistance devices. In addition to the need for an effective treatment for these conditions, there are also indications for controlling the blood flow that contribute to aneurysms and tumor cell vascularization.

TREC, TIBI, & One Lambda Inc. Launch Mass Media Campaign to Promote Living Donation

November 25, 2020

The Transplant Research and Education Center (TREC), in partnership with the Terasaki Institute for Biomedical Innovation and One Lambda Inc., on October 21st launched a 6-month mass media campaign to raise awareness about the Living Donation Storytelling Project. The campaign seeks to reach kidney and transplant patients, living donors, and nephrology, dialysis, and transplant professionals across the nation to help them learn about the innovative educational resources available through the Living Donation Storytelling Project. The Living Donation Storytelling Project is an online digital library of video stories recorded by real living donors, recipients, family members, and those in need of a kidney.

Television and Medicine: Patients, Donors, and Medical Professionals Respond to New CBS Sitcom about Living Donation

November 20, 2020

On November 5th, five million people watched the premiere of a new CBS show about living donation! B Positive is a new comedy sitcom following one man’s living donation journey. Drew, a therapist and single dad, is shocked to find out his kidneys are failing and he’s in urgent need of a transplant. With a rare blood type and lacking friends or family to ask to be his donor, Drew feels hopeless until he runs into an old high school acquaintance—Gina. Gina spontaneously offers to be his donor in her quest to do something bigger than herself.